FIELD: chemistry.
SUBSTANCE: invention relates to a method of producing optionally substituted 4-(benzimidazo-2-yl methylamino)benzamidine of formula (I) in which R1 denotes a methyl group, R2 denotes a R21NR22 group, where R21 denotes an ethyl group which is substituted with an ethoxycarbonyl group, and R22 denotes a pyridin-2-yl group, R3 denotes an n-hexyloxycarbonyl group, where at step (a) phenyldiamine of formula (II) where R1 and R2 assume values given for formula (I), which reacts with 2-[4-(1,2,4-oxadiazol-5-on-3-yl)phenylamino]acetic acid, to obtain a product of formula (III) where R1 and R2 assume values given for formula (I), which is hydrogenated at temperature from 30 to 60°C at hydrogen pressure from 1 to 10 bar, over palladium on activated charcoal (Pd/C) in a mixture of tetrahydrofuran and water, and then, without any preliminary extraction of the hydrogenation product, the obtained compound of formula (I), in which R3 denotes hydrogen, in the presence of potassium carbonate reacts with a compound of formula (IV) R3-X (IV), where R3 assumes values given for formula (I), and X denotes a suitable splitting group.
EFFECT: simple method of producing optionally substituted 4-(benzimidazo-2-yl methylamino)benzamidine.
3 cl, 9 ex
Title | Year | Author | Number |
---|---|---|---|
IMPROVED METHOD OF PRODUCING 4-BENZIMIDAZOLYL METHYLAMINO)-BENZAMIDE SALTS | 2006 |
|
RU2425827C2 |
4-(BENZIMIDAZOLYL-METHYLAMINO)BENZAMIDINE SYNTHESIS METHOD | 2005 |
|
RU2401264C2 |
METHOD OF PRODUCING INTERMEDIATE PRODUCT FOR SYNTHESIS OF DABIGATRAN ETEXILATE | 2009 |
|
RU2524212C2 |
HETEROCYCLIC COMPOUNDS, PHARMACEUTICAL COMPOSITION SHOWING ANTAGONISTIC ACTIVITY WITH RESPECT TO ANGIOTENSIN-II AND A METHOD OF ANTAGONIZATION OF ANGIOTENSIN-II IN MAMMALS | 1992 |
|
RU2104276C1 |
SERINE PROTEASE INHIBITORS, PHARMACEUTICAL COMPOSITION AND THERAPEUTICAL METHODS BASED ON THE SAME | 2000 |
|
RU2252935C2 |
DERIVATIVES OF BENZAMIDINE, METHOD OF THEIR SYNTHESIS AND PHARMACEUTICAL COMPOSITION | 1998 |
|
RU2194044C2 |
OXADIAZOLE-BASED CHANNEL INHIBITORS WITH TRANSIENT POTENTIAL | 2019 |
|
RU2818244C2 |
HETEROCYCLIC COMPOUND, PHARMACEUTICAL COMPOSITION, METHOD OF ANTAGONISM OF ANGIOTENSIN-II | 1992 |
|
RU2168510C2 |
HETEROCOMPOUND | 2007 |
|
RU2425832C2 |
SULFONEAMIDOCARBOXAMIDES, THEIR HYDRATES AND PHYSIOLOGICALLY ACCEPTABLE SALTS, PHARMACEUTICAL COMPOSITION ON SAID | 1993 |
|
RU2133739C1 |
Authors
Dates
2012-07-10—Published
2006-12-20—Filed